{"Symbol": "IQV", "AssetType": "Common Stock", "Name": "IQVIA Holdings Inc", "Description": "IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.", "CIK": "1478242", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "TRADE & SERVICES", "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH", "Address": "4820 EMPEROR BLVD., DURHAM, NC, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "50942726000", "EBITDA": "2342000000", "PERatio": "67.87", "PEGRatio": "1.03", "BookValue": "30.5", "DividendPerShare": "None", "DividendYield": "0", "EPS": "3.929", "RevenuePerShareTTM": "70.7", "ProfitMargin": "0.0567", "OperatingMarginTTM": "0.0933", "ReturnOnAssetsTTM": "0.033", "ReturnOnEquityTTM": "0.131", "RevenueTTM": "13536000000", "GrossProfitTTM": "3859000000", "DilutedEPSTTM": "3.929", "QuarterlyEarningsGrowthYOY": "1.577", "QuarterlyRevenueGrowthYOY": "0.217", "AnalystTargetPrice": "300.22", "TrailingPE": "67.87", "ForwardPE": "26.6", "PriceToSalesRatioTTM": "3.764", "PriceToBookRatio": "8.79", "EVToRevenue": "4.592", "EVToEBITDA": "23.2", "Beta": "1.403", "52WeekHigh": "272.25", "52WeekLow": "165.52", "50DayMovingAverage": "252.25", "200DayMovingAverage": "233.92", "SharesOutstanding": "191040000", "DividendDate": "None", "ExDividendDate": "None"}